US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 3.610
  • +0.150+4.34%
Close Jan 3 16:00 ET
  • 3.590
  • -0.020-0.55%
Post 19:56 ET
538.18MMarket Cap-8.40P/E (TTM)

Xeris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xeris Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
51.43M
54.27M
+2.83M
Beat Est.
+6.44%
+12.31%
+5.51%
EPS
-0.09
-0.11
-0.02
Miss Est.
0.00%
-22.22%
-22.36%
Analyst Rating
Strong Buy

Jan 4, 2025

Xeris Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.667M--
--2024/Q4-- / 56.740M--
Nov 8, 20242024/Q354.268M / 51.433M--
Aug 8, 20242024/Q248.065M / 45.811M--
May 9, 20242024/Q140.638M / 41.815M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.667M--
--2024/Q4-- / 56.740M--
Nov 8, 20242024/Q354.268M / 51.433M--
Aug 8, 20242024/Q248.065M / 45.811M--
May 9, 20242024/Q140.638M / 41.815M--

Unlock Free Earnings Estimates

Xeris Pharmaceuticals Earnings Reports

  • Xeris Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 9, 2024 05:05

  • Xeris Pharmaceuticals | 8-K: XERIS BIOPHARMA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

    Nov 8, 2024 20:15

  • Xeris Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 9, 2024 04:44

  • Xeris Pharmaceuticals | 8-K: XERIS XERIS BIOPHARMA REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

    Aug 8, 2024 19:19

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 4, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data